questionsmedicales.fr
Troubles mentaux
Troubles neurocognitifs
Démence
Démence : Questions médicales fréquentes
Termes MeSH sélectionnés :
Language Development Disorders
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Démence : Questions médicales les plus fréquentes",
"headline": "Démence : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Démence : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-13",
"dateModified": "2025-05-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Démence"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Troubles neurocognitifs",
"url": "https://questionsmedicales.fr/mesh/D019965",
"about": {
"@type": "MedicalCondition",
"name": "Troubles neurocognitifs",
"code": {
"@type": "MedicalCode",
"code": "D019965",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Démence associée au SIDA",
"alternateName": "AIDS Dementia Complex",
"url": "https://questionsmedicales.fr/mesh/D015526",
"about": {
"@type": "MedicalCondition",
"name": "Démence associée au SIDA",
"code": {
"@type": "MedicalCode",
"code": "D015526",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.050"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie d'Alzheimer",
"alternateName": "Alzheimer Disease",
"url": "https://questionsmedicales.fr/mesh/D000544",
"about": {
"@type": "MedicalCondition",
"name": "Maladie d'Alzheimer",
"code": {
"@type": "MedicalCode",
"code": "D000544",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Aphasie progressive primaire",
"alternateName": "Aphasia, Primary Progressive",
"url": "https://questionsmedicales.fr/mesh/D018888",
"about": {
"@type": "MedicalCondition",
"name": "Aphasie progressive primaire",
"code": {
"@type": "MedicalCode",
"code": "D018888",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.125"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Creutzfeldt-Jakob",
"alternateName": "Creutzfeldt-Jakob Syndrome",
"url": "https://questionsmedicales.fr/mesh/D007562",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Creutzfeldt-Jakob",
"code": {
"@type": "MedicalCode",
"code": "D007562",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Démence vasculaire",
"alternateName": "Dementia, Vascular",
"url": "https://questionsmedicales.fr/mesh/D015140",
"about": {
"@type": "MedicalCondition",
"name": "Démence vasculaire",
"code": {
"@type": "MedicalCode",
"code": "D015140",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.350"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Démence par infarctus multiples",
"alternateName": "Dementia, Multi-Infarct",
"url": "https://questionsmedicales.fr/mesh/D015161",
"about": {
"@type": "MedicalCondition",
"name": "Démence par infarctus multiples",
"code": {
"@type": "MedicalCode",
"code": "D015161",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.350.400"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Kosaka-Shibayama",
"alternateName": "Diffuse Neurofibrillary Tangles with Calcification",
"url": "https://questionsmedicales.fr/mesh/D055956",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Kosaka-Shibayama",
"code": {
"@type": "MedicalCode",
"code": "D055956",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.370"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dégénérescence lobaire frontotemporale",
"alternateName": "Frontotemporal Lobar Degeneration",
"url": "https://questionsmedicales.fr/mesh/D057174",
"about": {
"@type": "MedicalCondition",
"name": "Dégénérescence lobaire frontotemporale",
"code": {
"@type": "MedicalCode",
"code": "D057174",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.380"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Démence frontotemporale",
"alternateName": "Frontotemporal Dementia",
"url": "https://questionsmedicales.fr/mesh/D057180",
"about": {
"@type": "MedicalCondition",
"name": "Démence frontotemporale",
"code": {
"@type": "MedicalCode",
"code": "D057180",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.380.299"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Démence de Pick",
"alternateName": "Pick Disease of the Brain",
"url": "https://questionsmedicales.fr/mesh/D020774",
"about": {
"@type": "MedicalCondition",
"name": "Démence de Pick",
"code": {
"@type": "MedicalCode",
"code": "D020774",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.380.299.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Démence de Pick",
"alternateName": "Pick Disease of the Brain",
"url": "https://questionsmedicales.fr/mesh/D020774",
"about": {
"@type": "MedicalCondition",
"name": "Démence de Pick",
"code": {
"@type": "MedicalCode",
"code": "D020774",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.380.299.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Aphasie primaire progressive non fluente",
"alternateName": "Primary Progressive Nonfluent Aphasia",
"url": "https://questionsmedicales.fr/mesh/D057178",
"about": {
"@type": "MedicalCondition",
"name": "Aphasie primaire progressive non fluente",
"code": {
"@type": "MedicalCode",
"code": "D057178",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.380.600"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Huntington",
"alternateName": "Huntington Disease",
"url": "https://questionsmedicales.fr/mesh/D006816",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Huntington",
"code": {
"@type": "MedicalCode",
"code": "D006816",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.390"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndrome de Klüver-Bucy",
"alternateName": "Kluver-Bucy Syndrome",
"url": "https://questionsmedicales.fr/mesh/D020232",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Klüver-Bucy",
"code": {
"@type": "MedicalCode",
"code": "D020232",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.431"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie à corps de Lewy",
"alternateName": "Lewy Body Disease",
"url": "https://questionsmedicales.fr/mesh/D020961",
"about": {
"@type": "MedicalCondition",
"name": "Maladie à corps de Lewy",
"code": {
"@type": "MedicalCode",
"code": "D020961",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.512"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Démences mixtes",
"alternateName": "Mixed Dementias",
"url": "https://questionsmedicales.fr/mesh/D000093902",
"about": {
"@type": "MedicalCondition",
"name": "Démences mixtes",
"code": {
"@type": "MedicalCode",
"code": "D000093902",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.756"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Démence",
"alternateName": "Dementia",
"code": {
"@type": "MedicalCode",
"code": "D003704",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Birgit Teichmann",
"url": "https://questionsmedicales.fr/author/Birgit%20Teichmann",
"affiliation": {
"@type": "Organization",
"name": "Network Aging Research, Heidelberg University, Heidelberg, Germany."
}
},
{
"@type": "Person",
"name": "Amy Pepper",
"url": "https://questionsmedicales.fr/author/Amy%20Pepper",
"affiliation": {
"@type": "Organization",
"name": "Admiral Nurse Research Assistant, Dementia UK."
}
},
{
"@type": "Person",
"name": "Magda Tsolaki",
"url": "https://questionsmedicales.fr/author/Magda%20Tsolaki",
"affiliation": {
"@type": "Organization",
"name": "Greek Association of Alzheimer's Disease and Related Disorders (GAADRD), Thessaloniki, Greece."
}
},
{
"@type": "Person",
"name": "Nicole Darlington",
"url": "https://questionsmedicales.fr/author/Nicole%20Darlington",
"affiliation": {
"@type": "Organization",
"name": "Centre for Research in Public Health and Community Care, 3769University of Hertfordshire, Hertfordshire, UK."
}
},
{
"@type": "Person",
"name": "Michael Woodward",
"url": "https://questionsmedicales.fr/author/Michael%20Woodward",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Medicine and Health Sciences, 83726University of East Anglia, Norwich, UK."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "PAX9 in Cancer Development.",
"datePublished": "2022-05-17",
"url": "https://questionsmedicales.fr/article/35628401",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms23105589"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development of minimally invasive",
"datePublished": "2022-05-11",
"url": "https://questionsmedicales.fr/article/35585965",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ymgmr.2022.100880"
}
},
{
"@type": "ScholarlyArticle",
"name": "Functional impairment, insight, and comparison between criteria for gaming disorder in the International Classification of Diseases, 11 Edition and internet gaming disorder in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition.",
"datePublished": "2022-11-02",
"url": "https://questionsmedicales.fr/article/36326855",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1556/2006.2022.00079"
}
},
{
"@type": "ScholarlyArticle",
"name": "Harnessing a T1 Phage-Derived Spanin for Developing Phage-Based Antimicrobial Development.",
"datePublished": "2024-03-20",
"url": "https://questionsmedicales.fr/article/38516182",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.34133/bdr.0028"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development and validation of a youth climate anxiety scale for the Youth Development Instrument survey.",
"datePublished": "2023-08-21",
"url": "https://questionsmedicales.fr/article/37605318",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/inm.13201"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Troubles mentaux",
"item": "https://questionsmedicales.fr/mesh/D001523"
},
{
"@type": "ListItem",
"position": 3,
"name": "Troubles neurocognitifs",
"item": "https://questionsmedicales.fr/mesh/D019965"
},
{
"@type": "ListItem",
"position": 4,
"name": "Démence",
"item": "https://questionsmedicales.fr/mesh/D003704"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Démence - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Démence",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Démence",
"description": "Comment diagnostique-t-on la démence ?\nQuels tests sont utilisés pour diagnostiquer la démence ?\nLa démence peut-elle être confondue avec d'autres maladies ?\nQuels signes précoces indiquent une démence ?\nQui peut poser le diagnostic de démence ?",
"url": "https://questionsmedicales.fr/mesh/D003704?mesh_terms=Language+Development+Disorders&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Démence",
"description": "Quels sont les symptômes courants de la démence ?\nLa démence affecte-t-elle le langage ?\nLes hallucinations sont-elles un symptôme de démence ?\nComment la démence affecte-t-elle le comportement ?\nLes troubles du sommeil sont-ils liés à la démence ?",
"url": "https://questionsmedicales.fr/mesh/D003704?mesh_terms=Language+Development+Disorders&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Démence",
"description": "Peut-on prévenir la démence ?\nQuel rôle joue l'exercice physique dans la prévention ?\nL'alimentation méditerranéenne aide-t-elle à prévenir la démence ?\nLa stimulation cognitive est-elle bénéfique ?\nLe contrôle des facteurs de risque cardiovasculaires est-il important ?",
"url": "https://questionsmedicales.fr/mesh/D003704?mesh_terms=Language+Development+Disorders&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Démence",
"description": "Quels traitements existent pour la démence ?\nLes médicaments peuvent-ils ralentir la progression de la démence ?\nQuelles thérapies non médicamenteuses sont efficaces ?\nLes soins palliatifs sont-ils une option pour les patients ?\nComment la famille peut-elle aider un proche atteint de démence ?",
"url": "https://questionsmedicales.fr/mesh/D003704?mesh_terms=Language+Development+Disorders&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Démence",
"description": "Quelles complications peuvent survenir avec la démence ?\nLa démence augmente-t-elle le risque de dépression ?\nComment la démence affecte-t-elle la nutrition ?\nLes comportements agressifs sont-ils une complication ?\nLa démence peut-elle entraîner des problèmes de mobilité ?",
"url": "https://questionsmedicales.fr/mesh/D003704?mesh_terms=Language+Development+Disorders&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Démence",
"description": "Quels sont les principaux facteurs de risque de démence ?\nLe diabète est-il un facteur de risque pour la démence ?\nLe tabagisme influence-t-il le risque de démence ?\nLe niveau d'éducation joue-t-il un rôle ?\nLes traumatismes crâniens augmentent-ils le risque de démence ?",
"url": "https://questionsmedicales.fr/mesh/D003704?mesh_terms=Language+Development+Disorders&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on la démence ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'évaluation clinique, des tests cognitifs et des examens d'imagerie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour diagnostiquer la démence ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests neuropsychologiques, des bilans sanguins et des IRM peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "La démence peut-elle être confondue avec d'autres maladies ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles comme la dépression ou les troubles thyroïdiens peuvent simuler des symptômes."
}
},
{
"@type": "Question",
"name": "Quels signes précoces indiquent une démence ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des oublis fréquents, des difficultés à se concentrer et des changements de comportement."
}
},
{
"@type": "Question",
"name": "Qui peut poser le diagnostic de démence ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un médecin généraliste, un neurologue ou un gériatre peut établir le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de la démence ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent la perte de mémoire, la confusion, et des changements d'humeur."
}
},
{
"@type": "Question",
"name": "La démence affecte-t-elle le langage ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes peuvent avoir des difficultés à trouver les mots ou à suivre une conversation."
}
},
{
"@type": "Question",
"name": "Les hallucinations sont-elles un symptôme de démence ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines formes de démence, comme la démence à corps de Lewy, peuvent provoquer des hallucinations."
}
},
{
"@type": "Question",
"name": "Comment la démence affecte-t-elle le comportement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des changements de personnalité, de l'agitation ou de l'apathie."
}
},
{
"@type": "Question",
"name": "Les troubles du sommeil sont-ils liés à la démence ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les troubles du sommeil sont fréquents chez les personnes atteintes de démence."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la démence ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent que l'exercice, une alimentation saine et la stimulation cognitive peuvent aider."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'exercice physique dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exercice régulier peut améliorer la santé cérébrale et réduire le risque de démence."
}
},
{
"@type": "Question",
"name": "L'alimentation méditerranéenne aide-t-elle à prévenir la démence ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, cette alimentation riche en fruits, légumes et oméga-3 est associée à un risque réduit."
}
},
{
"@type": "Question",
"name": "La stimulation cognitive est-elle bénéfique ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des activités comme la lecture, les puzzles et les jeux de société peuvent aider."
}
},
{
"@type": "Question",
"name": "Le contrôle des facteurs de risque cardiovasculaires est-il important ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, gérer l'hypertension, le diabète et le cholestérol peut réduire le risque de démence."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour la démence ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments pour gérer les symptômes et des thérapies non médicamenteuses."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils ralentir la progression de la démence ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments peuvent ralentir la progression, mais ils ne guérissent pas la maladie."
}
},
{
"@type": "Question",
"name": "Quelles thérapies non médicamenteuses sont efficaces ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie occupationnelle, la musicothérapie et les activités sociales peuvent aider."
}
},
{
"@type": "Question",
"name": "Les soins palliatifs sont-ils une option pour les patients ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les soins palliatifs peuvent améliorer la qualité de vie en fin de vie."
}
},
{
"@type": "Question",
"name": "Comment la famille peut-elle aider un proche atteint de démence ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La famille peut offrir un soutien émotionnel, aider à la gestion des soins et à la communication."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la démence ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections, des chutes et des problèmes nutritionnels."
}
},
{
"@type": "Question",
"name": "La démence augmente-t-elle le risque de dépression ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes atteintes de démence sont plus susceptibles de développer une dépression."
}
},
{
"@type": "Question",
"name": "Comment la démence affecte-t-elle la nutrition ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes peuvent avoir des difficultés à manger, entraînant une malnutrition."
}
},
{
"@type": "Question",
"name": "Les comportements agressifs sont-ils une complication ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent développer des comportements agressifs ou agités."
}
},
{
"@type": "Question",
"name": "La démence peut-elle entraîner des problèmes de mobilité ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la démence peut affecter la coordination et l'équilibre, augmentant le risque de chutes."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque de démence ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, les antécédents familiaux et les maladies cardiovasculaires sont des facteurs clés."
}
},
{
"@type": "Question",
"name": "Le diabète est-il un facteur de risque pour la démence ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète mal contrôlé augmente le risque de développer une démence."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le risque de démence ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est associé à un risque accru de démence et de déclin cognitif."
}
},
{
"@type": "Question",
"name": "Le niveau d'éducation joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un niveau d'éducation plus élevé est souvent associé à un risque réduit de démence."
}
},
{
"@type": "Question",
"name": "Les traumatismes crâniens augmentent-ils le risque de démence ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traumatismes crâniens répétés peuvent augmenter le risque de démence à long terme."
}
}
]
}
]
}
Paired box 9 (PAX9) is a transcription factor of the PAX family functioning as both a transcriptional activator and repressor. Its functional roles in the embryonic development of various tissues and ...
Glycogen storage disease type Ia (GSD Ia) is an autosomal recessive disorder caused by deficiency of glucose-6-phosphatase (G6Pase), resulting in fasting hypoglycemia. Dietary treatment with provision...
Our objectives were: 1) establishing the use of a minimally invasive...
This study evaluated the consistency between the International Classification of Diseases, 11th Edition (ICD-11) for gaming disorder (ICD-11-GD) and Diagnostic and Statistical Manual of Mental Disorde...
We recruited 60 participants with GD, 45 participants who engaged in hazardous gaming (HG), and 120 controls based on a diagnostic interview. Their operationalization of functional impairment and stag...
We observed satisfactory consistency (kappa value = 0.80) with a diagnostic accuracy of 91.5% between the ICD-11-GD and DSM-5-IGD criteria. Furthermore, 16 participants with IGD in DSM-5 were determin...
There is a good consistency between ICD-11-GD and DSM-5-IGD criteria. The ICD-11 criteria have a high threshold for diagnosing GD. HG criteria could compensate for this high threshold and identify ind...
The global increase in the prevalence of drug-resistant bacteria has necessitated the development of alternative treatments that do not rely on conventional antimicrobial agents. Using bacteriophage-d...
Emerging terms in the literature such as climate anxiety describe heightened concern, fear, and anxiety related to the climate crisis. Recent efforts have attempted to develop and validate scales to m...
While evaluation of research-to-policy projects is a fundamental aspect of measuring the impact of new knowledge, limited studies have examined evaluation methods in such projects, as well as how the ...
In light of the expanding role of pharmacy in addressing global health challenges of Universal Health Coverage, advancing pharmacy practice to provide more effective pharmaceutical services has become...
A mixed methods approach was used to conduct a series of exploration, development, and consensus phases. The exploratory stage included desk research focused on innovative pharmaceutical provision glo...
The exploratory stage produced a draft set of 13 unvalidated FIP Practice Development Goals (DGs) Framework (v0). Initial analysis of the mNGT showed complex intersections between the proposed set of ...
A systematic goals-oriented development framework was developed to respond to pharmaceutical development needs and support a needs-based roadmap for a sustainable pharmacy practice transformation glob...
Pharmacy education shifts toward competency-based training to meet healthcare demands. This study aims to develop and validate the Kuwait Advanced Competency Framework (KACF) for pharmacists. The stud...
This is a mixed methods study that employed an "adopt and adapt" approach. The KACF was adopted from the FIP GADF and adapted following four phases. Phase one involved checking and validating the Arab...
The translation phase verified a bilingual framework that could be utilized by pharmacists in Kuwait. The initial and final validation phases identified 20 behavioral statements (out of 22 in the orig...
The KACF emerges as a pivotal tool for advancing pharmacy services in Kuwait, aligning with global trends toward competency-based education. Findings underscored the necessity for context-specific app...
The Accreditation Council for Pharmacy Education (ACPE) defines continuing professional development (CPD) as a self-directed, ongoing, systematic, and outcomes-focused approach to lifelong learning th...
This was an exploratory study using cross-sectional surveys and pharmacist self-reported CPD data at a community health system in the Southeastern USA. Surveys evaluating perceived value and use of CP...
Overall, fifty-seven (33.1%) pharmacists and twelve (85.7%) pharmacy managers and directors responded to surveys. A total of 13 (22.8%) respondents strongly agreed and 21 (36.8%) respondents agreed th...
The CPD framework may be a useful approach to support pharmacist development in hospital and health system settings and facilitate performance reviews....
Mood swings, or mood variability, are associated with negative mental health outcomes. Since adolescence is a time when mood disorder onset peaks, mood variability during this time is of significant i...